Europe’s medical devices industry saw a drop of 24.24% in deal activity during May 2021, when compared with the last 12-month average, led by Murano Bidco’s $1.36bn acquisition of Vectura Group, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 25 medical devices industry deals worth $2.6bn were announced for the region in May 2021, against the 12-month average of 33 deals.
Of all the deal types, venture financing saw most activity in May 2021 with 13 transactions, representing a 52% share for the region.
In second place was M&A with seven deals, followed by private equity deals with five transactions, respectively capturing a 28% and 20% share of the overall deal activity for the month.
In terms of value of deals, M&A was the leading category in Europe’s medical devices industry with $1.91bn, while private equity and venture financing deals totalled $383.58m and $292.02m, respectively.
Europe medical devices industry deals in May 2021: Top deals
The top five medical devices deals accounted for 89.4% of the overall value during May 2021.
The combined value of the top five medical devices deals stood at $2.31bn, against the overall value of $2.6bn recorded for the month.
The top five medical devices industry deals of May 2021 tracked by GlobalData were:
1) Murano Bidco’s $1.36bn acquisition of Vectura Group
2) The $390m acquisition deal with Inivata by NeoGenomics
3) IP Group, M&G Investments, Nikon, Temasek Holdings (Private) and Wellington ManagementLLP’s $280.17m private equity deal with Oxford Nanopore Technologies
4) The $155m acquisition of Immunodiagnostic Systems by PerkinElmer
5) HAT SGR, Hitachi Ventures, Leaps by Bayer, Samsung NEXT Fund, Sony Innovation Fund and Unilever Ventures’ venture financing of Huma Therapeutics for $130m.